Borderless Access Launches #HealthSight# - A Programmatic Sampling Suite for Healthcare Research

Food and Healthcare Press Releases Thursday September 7, 2017 13:32
BANGALORE, CALIFORNIA and LONDON--7 Sep--PRNewswire/InfoQuest

Borderless Access, a global digital MR solutions company enters into healthcare research with the launch of its new product offering 'HealthSight', in line with its vision to be the global leader in providing digital market research solutions for collating and analysing life moments, and experiences of hard-to-reach audiences, in growing and developed markets of the world; driven by advanced analytics and technology.

(Logo: http://photos.prnewswire.com/prnh/20161017/429158LOGO )

The HealthSight platform driven by an advanced analytics engine 'SmartSight', is an end-to-end solution for healthcare research, enabling access to 150,000+ proprietary specialist physicians panel as well as provide global customers to check and test the feasibility of market research sampling designs, thereby allowing the customers to optimize their sampling and reducing project costs.

Hosted on HealthSight, the new proprietary physician panels are for developed healthcare markets such as US, UK, Canada along with growing healthcare hubs in countries like India. The HCP panels focus on general and lifestyle disease practice, orphan disease practice, and healthcare ancillary services.

Ruchika Gupta, CEO of Borderless Access says, "We are widening our network and service offering, with a unique combination of a proprietary physician panel platform due to the growing demand from clients looking for simpler research and panel design services in the healthcare space. Our HealthSight product would make clients and other Honomichl research companies more confident in the representative outcomes further increasing the market research scope and size and decreasing costs in healthcare research."

With close to 3.1 million existing panelists, this new proprietary physician panel of 150,000+ doctors and specialist physicians provides extensive targeting abilities and accuracy. To provide the additional insights towards the trends and perceptions, panel members are deeply profiled including the attributes on the segregated scenario of global markets.

Borderless Access, a global digital MR solutions company, provides access to experiences and life moments of engaged consumers from hard-to-reach audiences (consumers, B2B & specialist audiences, including healthcare) in the emerging and developed markets, driven by Technology & Community Analytics to its global clientele of MR firms, Ad agencies, consultancy firms, and end enterprises.

Its focus on innovation extends to providing market research products and solutions, such as Panel Solutions, SmartSight, HealthSight, and TAPP.
For more information, please visit: https://www.borderlessaccess.com/
Media Contact:
Anshul Agarwal
Marketing@borderlessaccess.com
Source: Borderless Access Panels Pvt Ltd.

Latest Press Release

Covaris Introduces the 96 oneTUBE-10 AFA Plate for Improved NGS Workflows

Today, Covaris Inc. announced the release of the 96 oneTUBE-10 AFA Plate, which enables scalable and simplified workflows by leveraging Covaris' gold standard focused-acoustic technology to meet rapidly increasing Next-Generation Sequencing (NGS) demands...

2018 Empire State Building Run-Up Lottery Registration Opens on November 14, 2017

Runners must enter by December 10 for a chance to participate in the 41st Annual Run-Up on Wednesday, February 7, 2018, at 8:00 p.m. Empire State Realty Trust, Inc. (NYSE: ESRT) today announced that lottery registration for the 2018 Empire State...

Alpinion Medical Systems Launches E-CUBE 8, the New Ultrasound Diagnostic System

One of South Korea's global medical device manufacturers, Alpinion Medical Systems introduced its new E-CUBE 8, the latest and last addition to the E-CUBE lineup. The E-CUBE 8 is a smart, reliable product that ensures high performance with outstanding...

Photo Release: The Royal Danish Embassy and Novo Nordisk Pharma (Thailand) Co., Ltd launch the Blueprint for Change address Diabetes challenge , aligned with national NCD targets

On the 5th November 2017, right after the WDD event at the Vachirabenjatas Park (Suan Rot Fai Park) . Mr.Uffe Wolffhechel, the ambassador of the Royal Danish Embassy, Thailand (right) together with Mr.Mihai Irimescu, General Manager of Novo Nordisk...

Stryker announces publication of the DAWN(TM) Trial results in the New England Journal of Medicine

The New England Journal of Medicine published the results of the DAWN Trial, the first to provide compelling evidence in treating late window and wake-up stroke patients with mechanical thrombectomy. Currently, less than one in 10 patients suffering from...

Related Topics